Enhanced tissue plasminogen activator synthesis by the sympathetic neurons that innervate aging vessels

Journal of Neuroscience Research

Volumn 71, Issue 4, 2003, Pages 567-574

  Jiang, Xi ^a   Hand, Arthur R ^a   Shen, Shujing ^a   Cone, Robert E ^a   O'Rourke, James ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Aging vessels; Sympathetic neurons; Tissue plasminogen activator

Indexed keywords

MESSENGER RNA; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MESENTERIC ARTERY; MESSENGER RNA SYNTHESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL;

ADRENERGIC FIBERS; AGING; ANIMALS; FEMALE; MESENTERIC ARTERIES; RATS; RATS, INBRED F344; RNA, MESSENGER; SUPERIOR CERVICAL GANGLION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037441466     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10506     Document Type: Article

References (38)

1. Bashkov GV, Sergeev I, Medvedeva NA. 1993. Role of sympathetic cholinergic pathway in the neurogenous control of tissue-type plasminogen activator release into the blood. Blood Coagul Fibrinolysis 4:993-998.
2. Biggs R, MacFarlane R, Pilling J. 1947. Observation on fibrinolysis experimental activity produced by exercise or adrenaline. Lancet i:402-405.
3. Blinc A, Fras Z, Stegnar M, Keber D. 1999. Research in fibrinolysis and proteolysis is focusing on extracellular matrix degradation and vascular biology. Fibrinolysis Proteolysis 13:47-48.
4. Buczko W, Iacoviello L, De Curtis A, Amore C, Donati MB. 1991. Aging and tissue plasminogen activator release. Thromb Haemost 66:745.
5. Collen D. 1999. The plasminogen (fibrinolytic) system. Thromb Haemost 82:259-270.
6. DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF. 1997. Fibrinolytic responses to acute physical activity in older hypertensive men. J Appl Physiol 82:1765-1770.
7. DeSouza CA, Jones PP, Seals DR. 1998. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women. Arterioscler Thromb Vasc Biol 18:362-368.
8. Eliott HL, Summer DJ, McLean K, Reid JL. 1982. Effect of age on the responsiveness of vascular a-adrenoreceptors in man. J Cardiovasc Pharmacol 4:388-392.
9. Emeis JJ. 1988. Mechanisms involved in short term changes in blood levels of t-PA. In: Kluft C, editor. Tissue plasminogen activator (t-PA): physiological and clinical aspects, vol 2. Boca Raton, FL. CRC Press. p 21-35.
10. Fleg JL. 1986. Alterations in cardiovascular structure and function with advancing age. Am J Cardiol 57:33C-44C.
11. Galis ZS. 1999. Metalloproteases in remodeling of vascular extracellular matrix. Fibrinolysis Proteolysis 13:54-65.
12. Gleerup G, Winther K. 1995. The effect of aging on platelet function and fibrinolytic activity. Angiology 46:715-718.
13. Gualandris A, Jones TE, Strickland S, Tsirka SE. 1996. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 16:2220-2225.
14. Hajjar KA. 1995. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 74:294-301.
15. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M, Lawrence DA. 1997. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem 272:33062-33067.
16. Iacoviello L, D'Adamo MC, De Curtis A, Buczko W, Donati MB. 1995. Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats. Thromb Haemost 73:841-844.
17. Jern C, Selin L, Jern S. 1994. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 72:285-291.
18. Jiang X, Wang Y, Hand AR, Gillies C, Cone RE, O'Rourke J. 2000. Presence of tissue plasminogen activator (t-PA) in the adventitial sympathetic nerves that innervate small arteries: morphologic evidence for a neural fibrinolysis. Fibrinolysis Proteolysis 14:35-46.
19. Jiang X, Wang Y, Hand AR, Gillies C, Cone RE, Kirk J, O'Rourke J. 2002. Storage and release of tissue plasminogen activator (t-PA) by sympathetic axons in resistance vessel walls. Microvasc Res 64:438-447.
20. Kelley RP, Gallagher DE, Lee LL, O'Rourke MF. 1996. Arterial stiffness and vascular/ventricular interactions in humans. In: Loscalzo J, Creager MA, Dzan VJ, editors. Vascular medicine, 2nd ed. Boston: Little Brown Co. p 185-205.
21. Kohler HP, Grant PJ. 2000. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792-1801.
22. Li H, Grimes P. 1993. Adrenergic innervation of the choroid and iris in diabetic rats. Curr Eye Res 12:89-94.
23. Lijnen HR. 2000. Molecular interactions between the plasminogen/ plasmin and matrix metalloproteinase systems. Fibrinolysis Proteolysis 14:175-181.
24. Lochner JE, Kingma M, Kuhn S. 1985. Real-time imaging of the axonal transport of granules containing a tissue plasminogen activator/green fluorescent protein hybrid. Mol Biol Cell 9:2463-2476.
25. Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. 1997. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem 272:1976-1982.
26. Peng T, Jiang X, Wang Y, Hand AR, Gillies C, Cone RE, O'Rourke J. 1999. Sympathectomy decreases and adrenergic stimulation increases the release of tissue plasminogen activator from blood vessels. J Neurosci Res 56:680-692.
27. Pepper MS. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21:1104-1117.
28. Pittman R, Buettner HM. 1989. Degradation of extracellular matrix by neuronal proteases. Dev Neurosci 11:361-375.
29. Ranby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. 1986. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 32:2160-2165.
30. Schrauwen Y, de Vries REM, Kooistra T. 1994. Acute release of tissue plasminogen activator (t-PA) from the endothelium. Fibrinolysis 8:8-12.
31. Smalley DM, Fitzgerald JE, O'Rourke J. 1993. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs. Thromb Haemost 70:1043-1046.
32. Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB. 1991. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692-1697.
33. Takada Y, Takada A. 1989. Plasma levels of t-PA free PAI-1 and a complex of t-PA with PAI-1 in human males and females at various ages. Thromb Res 55:601-609.
34. Verstreate M, Bounameaux H, de Cock F, Van de Werf F, Collen D. 1985. Pharamcokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. J Pharmacol Exp Ther 235:506-512.
35. Wang Y, Gillies C, Cone RE, O'Rourke J. 1995. Extravascular secretion of t-PA by the intact superfused choroid. Invest Ophthalmol Vis Sci 36:1625-1632.
36. Wang Y, Hand AR, Gillies C, Grunnet ML, Cone RE, O'Rourke J. 1997. Morphologic evidence for a preferential storage of tissue plasminogen activator (t-PA) in perivascular axons of the rat uvea. Exp Eye Res 65:105-116.
37. Wang Y, Hand AR, Wang YH, Mina M, Gillies C, Peng T, Cone RE, O'Rourke J. 1998. Functional and morphologic evidence of the presence of tissue-plasminogen activator in vascular nerves: implications for a neurologic control of vessel wall fibrinolysis and rigidity. J Neurosci Res 53:443-453.
38. Wang Y, Jiang X, Hand A, Gillies C, Cone RE, O'Rourke J. 2002. Additional evidence that the sympathetic nervous system regulates the vessel wall release of tissue plasminogen activator. Blood Coagul Fibrinolysis 13:471-481.